160 related articles for article (PubMed ID: 19048402)
21. Nimesulide and indomethacin induce apoptosis in head and neck cancer cells.
Pelzmann M; Thurnher D; Gedlicka C; Martinek H; Knerer B
J Oral Pathol Med; 2004 Nov; 33(10):607-13. PubMed ID: 15482327
[TBL] [Abstract][Full Text] [Related]
22. [Establishment and biological characterization of 5-fluorouracil-resistant human colon cancer HT-29/5-FU cell line].
Qiu T; Xiang X; Lei W; Hao C; Zhang L; Feng M; Yu F; Li J; Xiong J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Mar; 31(3):328-32. PubMed ID: 25744837
[TBL] [Abstract][Full Text] [Related]
23. Dose-dependent modulation of apoptosis and cyclooxygenase-2 expression in human 1547 osteosarcoma cells by NS-398, a selective cyclooxygenase-2 inhibitor.
Moalic S; Liagre B; Le Bail JC; Beneytout JL
Int J Oncol; 2001 Mar; 18(3):533-40. PubMed ID: 11179483
[TBL] [Abstract][Full Text] [Related]
24. The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action.
Smith ML; Hawcroft G; Hull MA
Eur J Cancer; 2000 Mar; 36(5):664-74. PubMed ID: 10738133
[TBL] [Abstract][Full Text] [Related]
25. Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cells.
Cheng AS; Chan HL; Leung WK; Wong N; Johnson PJ; Sung JJ
Int J Oncol; 2003 Jul; 23(1):113-9. PubMed ID: 12792783
[TBL] [Abstract][Full Text] [Related]
26. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N
Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455
[TBL] [Abstract][Full Text] [Related]
27. Nonsteroidal anti-inflammatory drugs inhibit the growth of C6 and U138-MG glioma cell lines.
Bernardi A; Jacques-Silva MC; Delgado-Cañedo A; Lenz G; Battastini AM
Eur J Pharmacol; 2006 Feb; 532(3):214-22. PubMed ID: 16487511
[TBL] [Abstract][Full Text] [Related]
28. Polymorphic tandem repeat sequences of the thymidylate synthase gene correlates with cellular-based sensitivity to fluoropyrimidine antitumor agents.
Yawata A; Kim SR; Miyajima A; Kubo T; Ishida S; Saito Y; Nakajima Y; Katori N; Matsumoto Y; Fukuoka M; Ohno Y; Ozawa S; Sawada J
Cancer Chemother Pharmacol; 2005 Nov; 56(5):465-72. PubMed ID: 15918040
[TBL] [Abstract][Full Text] [Related]
29. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression.
Elder DJ; Halton DE; Hague A; Paraskeva C
Clin Cancer Res; 1997 Oct; 3(10):1679-83. PubMed ID: 9815550
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
[TBL] [Abstract][Full Text] [Related]
31. Cyclooxygenase-2 inhibitors demonstrate anti-proliferative effects in oesophageal cancer cells by prostaglandin E(2)-independent mechanisms.
Deasy BM; O'Sullivan-Coyne G; O'Donovan TR; McKenna SL; O'Sullivan GC
Cancer Lett; 2007 Oct; 256(2):246-58. PubMed ID: 17707579
[TBL] [Abstract][Full Text] [Related]
32. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
Hashitani S; Urade M; Nishimura N; Maeda T; Takaoka K; Noguchi K; Sakurai K
Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902
[TBL] [Abstract][Full Text] [Related]
33. Specific COX-2 inhibitor, meloxicam, suppresses proliferation and induces apoptosis in human HepG2 hepatocellular carcinoma cells.
Li J; Chen X; Dong X; Xu Z; Jiang H; Sun X
J Gastroenterol Hepatol; 2006 Dec; 21(12):1814-20. PubMed ID: 17074019
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M
Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467
[TBL] [Abstract][Full Text] [Related]
35. Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells.
Ding XZ; Tong WG; Adrian TE
Anticancer Res; 2000; 20(4):2625-31. PubMed ID: 10953335
[TBL] [Abstract][Full Text] [Related]
36. Cyclooxygenase-2 (COX-2) is directly involved but not decisive in proliferation of human hepatocellular carcinoma cells.
Park JW; Park JE; Lee JA; Lee CW; Kim CM
J Cancer Res Clin Oncol; 2006 Mar; 132(3):184-92. PubMed ID: 16331492
[TBL] [Abstract][Full Text] [Related]
37. Gossypol sensitizes the antitumor activity of 5-FU through down-regulation of thymidylate synthase in human colon carcinoma cells.
Yang D; Qu J; Qu X; Cao Y; Xu L; Hou K; Feng W; Liu Y
Cancer Chemother Pharmacol; 2015 Sep; 76(3):575-86. PubMed ID: 26208739
[TBL] [Abstract][Full Text] [Related]
38. Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis.
Rozic JG; Chakraborty C; Lala PK
Int J Cancer; 2001 Aug; 93(4):497-506. PubMed ID: 11477553
[TBL] [Abstract][Full Text] [Related]
39. Cyclooxygenase (COX) inhibitors induce apoptosis in non-small cell lung cancer through cyclooxygenase independent pathways.
Sánchez-Alcázar JA; Bradbury DA; Pang L; Knox AJ
Lung Cancer; 2003 Apr; 40(1):33-44. PubMed ID: 12660005
[TBL] [Abstract][Full Text] [Related]
40. Cyclooxygenase inhibitors induce apoptosis in sinonasal cancer cells by increased expression of nonsteroidal anti-inflammatory drug-activated gene.
Kim JH; Chang JH; Rhee KH; Yoon JH; Kwon SH; Song K; Lee KW; Cho CI; Jeon JH; Kim KS
Int J Cancer; 2008 Apr; 122(8):1765-73. PubMed ID: 18076062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
